News
BDSX
8.68
-2.25%
-0.20
BIODESIX, INC. BDSX INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 57% Share Drop
Barchart · 23h ago
Weekly Report: what happened at BDSX last week (1109-1113)?
Weekly Report · 2d ago
Biodesix Earnings Call Shows Growth Amid Execution Challenges
TipRanks · 3d ago
Friday 11/13 Insider Buying Report: BDSX, EQPT
NASDAQ · 4d ago
Biodesix Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 11/09 11:44
Biodesix Price Target Cut to $34.00/Share From $38.00 by HC Wainwright & Co.
Dow Jones · 11/09 11:44
Biodesix price target lowered to $34 from $38 at H.C. Wainwright
TipRanks · 11/09 11:15
Weekly Report: what happened at BDSX last week (1102-1106)?
Weekly Report · 11/09 10:09
Biodesix Is Maintained at Buy by Lake Street
Dow Jones · 11/07 01:39
Biodesix Price Target Cut to $30.00/Share From $40.00 by Lake Street
Dow Jones · 11/07 01:39
Lake Street Maintains Buy on Biodesix, Lowers Price Target to $30
Benzinga · 11/07 01:30
Gold Falls 1%; Charter Communications Shares Fall After Q3 Results
Benzinga · 11/06 17:11
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 11/06 17:05
Champions Oncology vs. Biodesix: Which Oncology Stock Is a Better Buy?
NASDAQ · 11/06 15:16
Nasdaq Jumps 400 Points; US Nonfarm Payrolls Top Estimates In October
Benzinga · 11/06 15:04
Biodesix price target lowered to $30 from $40 at Lake Street
TipRanks · 11/06 14:03
Biodesix price target lowered to $34 from $40 at TD Cowen
TipRanks · 11/06 13:56
Biodesix Shares Fall on Lower Outlook, Underwhelming 3Q Growth
Dow Jones · 11/06 13:48
DraftKings Posts Downbeat Q3 Results, Joins Atlassian, Natera And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
Benzinga · 11/06 13:03
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 11/06 12:05
More
Webull provides a variety of real-time BDSX stock news. You can receive the latest news about BIODESIX INC through multiple platforms. This information may help you make smarter investment decisions.
About BDSX
Biodesix, Inc. is a diagnostic solutions company. The Company's business includes Biodesix Lung Diagnostic Testing and Biodesix Development Services. Its Biodesix Lung Diagnostic Testing provides lung diagnostic testing services for healthcare providers through five blood-based tests. Its Biodesix Development Services supports global biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that enable the development of diagnostic tests, tools, and therapeutics. The Company offers Nodify Lung tests and IQLung tests that assess cancer risk and provide treatment guidance following a lung cancer diagnosis. The Nodify Lung tests include Nodify CDT and Nodify XL2 tests, which evaluate the risk of lung cancer in lung nodules. The GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests are used in the diagnosis of lung cancer to detect tumor mutations and assess the patient’s immune system status.